These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6316036)

  • 41. Effects of delta 9-tetrahydrocannabinol and social context on marijuana self-administration by humans.
    Kelly TH; Foltin RW; Mayr MT; Fischman MW
    Pharmacol Biochem Behav; 1994 Nov; 49(3):763-8. PubMed ID: 7862735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of the absorption phase of marijuana smoking.
    Huestis MA; Sampson AH; Holicky BJ; Henningfield JE; Cone EJ
    Clin Pharmacol Ther; 1992 Jul; 52(1):31-41. PubMed ID: 1320536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Action of delta-9-tetrahydrocannabinol. An approach to the active metabolite hypothesis.
    Hollister LE; Gillespie HK
    Clin Pharmacol Ther; 1975 Dec; 18(6):714-9. PubMed ID: 1204277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade.
    Kanakis C; Pouget JM; Rosen KM
    Circulation; 1976 Apr; 53(4):703-7. PubMed ID: 1253395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.
    Huestis MA; Mitchell JM; Cone EJ
    J Anal Toxicol; 1996 Oct; 20(6):441-52. PubMed ID: 8889681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction between warfarin and cannabis.
    Damkier P; Lassen D; Christensen MMH; Madsen KG; Hellfritzsch M; Pottegård A
    Basic Clin Pharmacol Toxicol; 2019 Jan; 124(1):28-31. PubMed ID: 30326170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Letter: Normal plasma testosterone concentrations after marihuana smoking.
    Schaefer CF; Gunn CG; Dubowski KM
    N Engl J Med; 1975 Apr; 292(16):867-8. PubMed ID: 1113821
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration.
    Schlienz NJ; Lee DC; Stitzer ML; Vandrey R
    Drug Alcohol Depend; 2018 Jun; 187():254-260. PubMed ID: 29689485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute effects of natural and synthetic cannabis compounds on prolactin levels in human males.
    Mendelson JH; Ellingboe J; Mello NK
    Pharmacol Biochem Behav; 1984 Jan; 20(1):103-6. PubMed ID: 6320226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phytohemagglutinin-induced lymphocyte transformation in humans receiving delta9-tetrahydrocannabinol.
    Lau RJ; Tubergen DG; Barr M; Domino EF; Benowitz N; Jones RT
    Science; 1976 May; 192(4241):805-7. PubMed ID: 1265484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.
    Levin FR; Mariani JJ; Pavlicova M; Brooks D; Glass A; Mahony A; Nunes EV; Bisaga A; Dakwar E; Carpenter KM; Sullivan MA; Choi JC
    Drug Alcohol Depend; 2016 Feb; 159():53-60. PubMed ID: 26711160
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 9 -Tetrahydrocannabinol and ethyl alcohol: evidence for cross-tolerance in the rat.
    Newman LM; Lutz MP; Gould MH; Domino EF
    Science; 1972 Mar; 175(4025):1022-3. PubMed ID: 5061865
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Marijuana and driving in real-life situations.
    Klonoff H
    Science; 1974 Oct; 186(4161):317-24. PubMed ID: 4414573
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations.
    Huestis MA; Barnes A; Smith ML
    Clin Chem; 2005 Dec; 51(12):2289-95. PubMed ID: 16223887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CB1-Dependent Long-Term Depression in Ventral Tegmental Area GABA Neurons: A Novel Target for Marijuana.
    Friend L; Weed J; Sandoval P; Nufer T; Ostlund I; Edwards JG
    J Neurosci; 2017 Nov; 37(45):10943-10954. PubMed ID: 29038246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concentration-effect relationship of delta-9-tetrahydrocannabiol and prediction of psychotropic effects after smoking marijuana.
    Harder S; Rietbrock S
    Int J Clin Pharmacol Ther; 1997 Apr; 35(4):155-9. PubMed ID: 9112136
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
    Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans.
    D'Souza DC; Pittman B; Perry E; Simen A
    Psychopharmacology (Berl); 2009 Mar; 202(4):569-78. PubMed ID: 18807247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Serum testosterone concentrations in cannabis and opiate users].
    Friedrich G; Nepita W; André T
    Beitr Gerichtl Med; 1990; 48():57-66. PubMed ID: 2241844
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns.
    Feinberg I; Jones R; Walker J; Cavness C; Floyd T
    Clin Pharmacol Ther; 1976 Jun; 19(6):782-94. PubMed ID: 178475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.